日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A randomized, double-blind, placebo-controlled trial of olanzapine versus placebo plus ondansetron and dexamethasone for antiemetic prophylaxis in patients receiving oxaliplatin-, irinotecan-, or carboplatin-based chemotherapy

一项随机、双盲、安慰剂对照试验,比较奥氮平与安慰剂联合昂丹司琼和地塞米松用于接受奥沙利铂、伊立替康或卡铂化疗患者的止吐预防效果。

Harikul, Warangkana; Nimmannit, Akarin; Laocharoenkeat, Apirom; Phisalprapa, Pochamana; Kositamongkol, Chayanis; Thongkijpreecha, Phurita; Ithimakin, Suthinee

Randomized controlled trial on the efficacy of topical urea-based cream in preventing capecitabine-associated hand-foot syndrome

一项关于局部应用尿素乳膏预防卡培他滨相关手足综合征疗效的随机对照试验

Wongkraisri, Concord; Chusuwanrak, Kriengkrai; Laocharoenkeat, Apirom; Chularojanamontri, Leena; Nimmannit, Akarin; Ithimakin, Suthinee

Clinical Outcomes of HER2-Low Versus HER2-Zero in HR-Positive Metastatic Breast Cancer Treated With Endocrine Therapy With or Without CDK4/6 Inhibitors: A Multicenter Retrospective Study

HER2低表达与HER2零表达的HR阳性转移性乳腺癌患者接受内分泌治疗(联合或不联合CDK4/6抑制剂)的临床结局:一项多中心回顾性研究

Susiriwatananont, Thiti; Wongkraisri, Concord; Dajsakdipon, Thanate; Supavavej, Archara; Dechaphunkul, Arunee; Sunpaweravong, Patrapim; Neesanun, Sunee; Ithimakin, Suthinee; Dejthevaporn, Thitiya; Parinyanitikul, Napa

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer

泛亚洲版ESMO临床实践指南:早期乳腺癌患者的诊断、治疗和随访

Park, K H; Loibl, S; Sohn, J; Park, Y H; Jiang, Z; Tadjoedin, H; Nag, S; Saji, S; Md Yusof, M; Villegas, E M B; Lim, E H; Lu, Y-S; Ithimakin, S; Tseng, L-M; Dejthevaporn, T; Chen, T W-W; Lee, S C; Galvez, C; Malwinder, S; Kogawa, T; Bajpai, J; Brahma, B; Wang, S; Curigliano, G; Yoshino, T; Kim, S-B; Pentheroudakis, G; Im, S-A; Andre, F; Ahn, J B; Harbeck, N

Comparative effectiveness analysis of survival with first-line palbociclib or ribociclib plus AI in HR + /HER2- advanced breast cancer (CEPRA study): preliminary analysis of real-world data from Thailand

比较帕博西尼或瑞博西尼联合AI治疗HR+/HER2-晚期乳腺癌患者的生存疗效(CEPRA研究):来自泰国的真实世界数据的初步分析

Dajsakdipon, Thanate; Susiriwatananont, Thiti; Wongkraisri, Concord; Ithimakin, Suthinee; Parinyanitikul, Napa; Supavavej, Archara; Dechaphunkul, Arunee; Sunpaweravong, Patrapim; Neesanun, Sunee; Akewanlop, Charuwan; Dejthevaporn, Thitiya

Disparities in Access to Systemic Treatment for Breast Cancer in Thailand and Major Asian Territories

泰国与亚洲主要地区在乳腺癌系统性治疗方面存在差异

Ithimakin, Suthinee; Parinyanitikul, Napa; Kim, Sung-Bae; Yap, Yoon-Sim; Tsang, Janice; Soong, Inda S; Ozaki, Yukinori; Ohno, Shinji; Ono, Makiko; Chan, Jack Junjie; Cheng, Hung Chun Skye; Dejthevaporn, Thitiya

Patterns and outcomes of immune-related adverse events in solid tumor patients treated with immune checkpoint inhibitors in Thailand: a multicenter analysis

泰国接受免疫检查点抑制剂治疗的实体瘤患者免疫相关不良事件的模式和结局:一项多中心分析

Ngamphaiboon, Nuttapong; Ithimakin, Suthinee; Siripoon, Teerada; Sintawichai, Nattaya; Sriuranpong, Virote

From presentation to paper: Gender disparities in oncological research

从报告到论文:肿瘤学研究中的性别差异

Dijksterhuis, Willemieke P M; Stroes, Charlotte I; Tan, Wan-Ling; Ithimakin, Suthinee; Calles, Antonio; van Oijen, Martijn G H; Verhoeven, Rob H A; Barriuso, Jorge; Oosting, Sjoukje F; Ivankovic, Daniela Kolarevic; Furness, Andrew J S; Bozovic-Spasojevic, Ivana; Gomez-Roca, Carlos; van Laarhoven, Hanneke W M

Predictive significance of cancer related-inflammatory markers in locally advanced rectal cancer

癌症相关炎症标志物在局部晚期直肠癌中的预测意义

Timudom, Kitinat; Akaraviputh, Thawatchai; Chinswangwatanakul, Vitoon; Pongpaibul, Ananya; Korpraphong, Pornpim; Petsuksiri, Janjira; Ithimakin, Suthinee; Trakarnsanga, Atthaphorn

Association between dietary patterns and disease recurrence in Thai colorectal cancer patients

泰国结直肠癌患者饮食模式与疾病复发之间的关联

Kunnavuttivanich, Vorraaud; Pramyothin, Pornpoj; Ithimakin, Suthinee